A. S. Butorina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
A. S. Butorina has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- A. S. Skobaro
St. Petersburg State University
1 shared publication - A. S. Sokolova
I.I. Mechnikov North-Western State Medical University
1 shared publication - Alexander Vladimirovich Korotkikh
Amur State Medical Academy of the Ministry of Health of the Russian Federation (Amur SMA)
1 shared publication - Alexey A. Sirotkin
Kostroma Regional Clinical Hospital named after E.I. Korolev, Kostroma, Russian Federation
1 shared publication - Anton Nikolaevich Kazantsev
135th Separate Medical Battalion of the Ministry of Defense of the Russian Federation
1 shared publication - Bogdan N. Kotiv
Military Medical Academy
1 shared publication
Latest Publications
- Open Access
- 12 September 2024
- Published by N.N. Blokhin Cancer Fund in Surgery and Oncology
- Vol. 14 (3) , 35-42
Robot-assisted surgery for rectal cancer in patients after neoadjuvant chemoradiotherapy Immediate results
Introduction. The benefits of robotic surgery for rectal cancer remain controversial. Only a few studies have evaluated the safety and feasibility of robot-assisted surgery after neoadjuvant chemoradiotherapy.Aim. Our study aimed to compare the short-term outcomes of robotic and traditional laparoscopic surgery after neoadjuvant chemoradiotherapy for rectal cancer.Materials and methods. This retrospective study was based on the analysis of 210 medical records of patients with rectal tumors who underwent robot-assisted and laparoscopic-assisted surgeries after neoadjuvant chemoradiotherapy from 2015 to 2021.Results. There was no significant difference in short-term outcomes such as operation time, conversion rate, anastomotic leakage, and quality of circular resection margin. However, a significant difference was noted in the quality of total mesorectal excision. Grade 3 quality in the R group was 93.9 %, while in the L group it was 74.07 % (Odds Ratio (OR) 2.335; 95 % Confidence Interval (CI) 1.107–4.925). A statistically significant difference was also found in the rate of performing sphincter-preserving procedures, with 12.2 % in the R group and 50 % in the L group (OR 0.139; 95 % CI 0.066–0.293).Conclusion. The advantages of the robotic surgical system in the surgical treatment of rectal cancer in patients after neoadjuvant chemoradiotherapy improve clinical outcomes, primarily reflected in the rate of sphincter-preserving operations. Additionally, it provides a trend towards achieving more oncologically adequate tumor removal compared to laparoscopic procedures.
- 12 September 2024
- Published by N.N. Blokhin Cancer Fund in Surgery and Oncology
- Vol. 14 (3) , 35-42
Open AccessRobot-assisted surgery for rectal cancer in patients after neoadjuvant chemoradiotherapy Immediate results
Introduction. The benefits of robotic surgery for rectal cancer remain controversial. Only a few studies have evaluated the safety and feasibility of robot-assisted surgery after neoadjuvant chemoradiotherapy.Aim. Our study aimed to compare the short-term outcomes of robotic and traditional laparoscopic surgery after neoadjuvant chemoradiotherapy for rectal cancer.Materials and methods. This retrospective study was based on the analysis of 210 medical records of patients with rectal tumors who underwent robot-assisted and laparoscopic-assisted surgeries after neoadjuvant chemoradiotherapy from 2015 to 2021.Results. There was no significant difference in short-term outcomes such as operation time, conversion rate, anastomotic leakage, and quality of circular resection margin. However, a significant difference was noted in the quality of total mesorectal excision. Grade 3 quality in the R group was 93.9 %, while in the L group it was 74.07 % (Odds Ratio (OR) 2.335; 95 % Confidence Interval (CI) 1.107–4.925). A statistically significant difference was also found in the rate of performing sphincter-preserving procedures, with 12.2 % in the R group and 50 % in the L group (OR 0.139; 95 % CI 0.066–0.293).Conclusion. The advantages of the robotic surgical system in the surgical treatment of rectal cancer in patients after neoadjuvant chemoradiotherapy improve clinical outcomes, primarily reflected in the rate of sphincter-preserving operations. Additionally, it provides a trend towards achieving more oncologically adequate tumor removal compared to laparoscopic procedures.
- Open Access
- 20 March 2023
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 28 (2) , 5309
"Festina lente" — a multicenter study on the outcomes of carotid endarterectomy, depending on vessel suturing speed
Aim. Analysis of inhospital and long-term outcomes of conventional carotid endarterectomy (CEA) depending on vessel suturing speed.Material and methods. The present prospective multicenter study for the period from March 1, 2017 to October 1, 2020 included 2366 patients who underwent conventional CEA with patch angioplasty. Depending on the time required to apply 1 stitch, 4 groups of patients were formed: group 1 (n=471; 19,9%) — 1 stitch per 2 seconds; group 2 (n=865; 36,5%) — 1 stitch per 3 seconds; group 3 (n=692; 29,2%) — 1 stitch per 4 seconds; group 4 (n=338; 14,3%) — 1 stitch per 5 seconds. The term "stitch" refers to two needle punctures. The follow-up postoperative period was 18,5±11,0 months.Results. There were no deaths and myocardial infarctions (MI) in the inhospital postoperative period. In group 1, anastomotic bleeding (n=93; 19,7%; pConclusion. 1. Vessel suturing at a speed of 1 stitch per 2 seconds is associated with an increased risk of intraoperative ICA thrombosis, bleeding along the anastomosis, stroke, as well as restenosis and stroke in the long-term follow-up period. 2. Vessel suturing at a speed of 1 stitch per 5 seconds is not accompanied by an increase in inhospital stroke rate, despite the maximum ICA occlusion time relative to other groups of patients. 3. Vessel suturing at a speed of 1 stitch per 3 or 4 seconds characterized by the lowest incidence of all complications at the inhospital and long-term stages of postoperative follow-up.
- 20 March 2023
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 28 (2) , 5309
Open Access"Festina lente" — a multicenter study on the outcomes of carotid endarterectomy, depending on vessel suturing speed
Aim. Analysis of inhospital and long-term outcomes of conventional carotid endarterectomy (CEA) depending on vessel suturing speed.Material and methods. The present prospective multicenter study for the period from March 1, 2017 to October 1, 2020 included 2366 patients who underwent conventional CEA with patch angioplasty. Depending on the time required to apply 1 stitch, 4 groups of patients were formed: group 1 (n=471; 19,9%) — 1 stitch per 2 seconds; group 2 (n=865; 36,5%) — 1 stitch per 3 seconds; group 3 (n=692; 29,2%) — 1 stitch per 4 seconds; group 4 (n=338; 14,3%) — 1 stitch per 5 seconds. The term "stitch" refers to two needle punctures. The follow-up postoperative period was 18,5±11,0 months.Results. There were no deaths and myocardial infarctions (MI) in the inhospital postoperative period. In group 1, anastomotic bleeding (n=93; 19,7%; pConclusion. 1. Vessel suturing at a speed of 1 stitch per 2 seconds is associated with an increased risk of intraoperative ICA thrombosis, bleeding along the anastomosis, stroke, as well as restenosis and stroke in the long-term follow-up period. 2. Vessel suturing at a speed of 1 stitch per 5 seconds is not accompanied by an increase in inhospital stroke rate, despite the maximum ICA occlusion time relative to other groups of patients. 3. Vessel suturing at a speed of 1 stitch per 3 or 4 seconds characterized by the lowest incidence of all complications at the inhospital and long-term stages of postoperative follow-up.